Altoran 40 Tablet 10

Altoran 40 Tablet 10 is not recommended during pregnancy, especially during the second and third trimesters, due to potential harm to the foetus. If you become pregnant while taking this medicine, discontinuation is advised as soon as possible.

The presence of azilsartan medoxomil in human milk is a potential risk to a nursing infant. This medicine is not recommended for breastfeeding women.

There's no specific information about interactions between alcohol and Altoran 40 Tablet 10. However, caution is advised when drinking alcohol while taking this medicine. Consult your doctor for more information.

Patients with mild or moderate liver impairment don't need any dosage adjustments for Altoran 40 Tablet 10. However, this medicine hasn't been studied in patients with severe liver impairment. It is best to consult your doctor before taking this medicine if you have any liver issues.

While no dose adjustment is necessary for patients with renal impairment, those with severe renal impairment or end-stage renal disease may be more sensitive to the hypotensive effects of Altoran 40 Tablet 10. Caution and regular monitoring are recommended.

Altoran 40 Tablet 10 may cause side effects such as dizziness, which could affect your ability to drive or operate machinery. If you experience any such side effects, avoid engaging in these activities until you feel well enough.

Altoran 40 Tablet 10 should not be taken if you have a known allergy to azilsartan medoxomil or any other components of the tablet.

The safety and effectiveness of Altoran 40 Tablet 10 in children have not been established. It is best to consult your doctor before giving this medicine to a child.

No significant differences in safety or effectiveness have been observed between older and younger patients. However, some older individuals may be more susceptible to the effects of Altoran 40 Tablet 10. Always take this medicine under medical supervision if you are an older patient.